MONDAY, Oct. 28, 2024 — For patients with a history of overt hepatic encephalopathy (OHE), rifaximin monotherapy (MT) results in significantly fewer OHE episodes than lactulose (LAC) MT, according to a study presented at the annual meeting of the…Original Article
ACG: Fewer Overt Hepatic Encephalopathy Episodes Seen With Rifaximin
MONDAY, Oct. 28, 2024 — For patients with a history of overt hepatic encephalopathy (OHE), rifaximin monotherapy (MT) results in significantly fewer OHE episodes than lactulose (LAC) MT, according to a study presented at the annual meeting of the…
